Article(id=1325193423690531226, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1325193240848245724, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2026.01.001, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1765728000000, receivedDateStr=2025-12-15, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1793880333110, onlineDateStr=2026-11-05, pubDate=1767974400000, pubDateStr=2026-01-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1793880333110, onlineIssueDateStr=2026-11-05, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1793880333110, creator=13701087609, updateTime=1793880333110, updator=13701087609, issue=Issue{id=1325193240848245724, tenantId=1146029695717560320, journalId=1319690259887390882, year='2026', volume='57', issue='1', pageStart='1', pageEnd='139', issueExtLink='null', onlineDate='null', pubDate='1767974400000', pubDateStr='2026-01-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1793880289518, creator='13701087609', updateTime=1793935523064, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1325424907554795952, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1325193240848245724, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1325424907554795953, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1325193240848245724, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1, endPage=28, ext={EN=ArticleExt(id=1325193423912829339, articleId=1325193423690531226, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Overviews of the New Drugs in 2025 Approved by U.S. FDA, columnId=1322624444355432649, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Perspective & Review, runingTitle=null, highlight=null, articleAbstract=

In 2025, FDA approved 46 new drugs for marketing, including 31 small molecule drugs and 15 biological products. Based on FDA-approved drug labeling, related databases, patents, and published literature, this review describes the chemical name, original research company, compound patent, time to market, indications, mechanism of action, dosage form and strengths, adverse effects and synthesis routes of those small molecule drugs, and the basic information about biological products.

, authors=Jiahui WANG1, 2, Bo HAN1, 2, Zixue ZHANG1, 2, Qingwei ZHANG1, 2, *, authorsList=Jiahui WANG, Bo HAN, Zixue ZHANG, Qingwei ZHANG, authorCompany=null, correspAuthors=Qingwei ZHANG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1325193426047730078, articleId=1325193423690531226, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=2025年美国FDA批准上市新药简介, columnId=1322624444544176331, journalTitle=中国医药工业杂志, columnName=专论与综述, runingTitle=null, highlight=null, articleAbstract=

2025年美国FDA批准上市新药46个,其中小分子药物31个,生物制品15个。根据FDA批准的新药说明书以及相关数据库、专利、文献报道,文章简要介绍了2025年FDA批准上市的小分子药物的化学名、原研公司、化合物专刊、上市时间、适应证、作用机制、剂型和规格、不良反应及合成路线等,以及生物制品的基本情况。

, authors=王佳辉1, 2, 韩博1, 2, 张子学1, 2, 张庆伟1, 2, *, authorsList=王佳辉, 韩博, 张子学, 张庆伟, authorCompany=null, correspAuthors=张庆伟, authorNote=

王佳辉,博士研究生,专业方向:药物化学。

张庆伟,医学博士,中国医药工业研究总院研究员、博士生导师,院一级学科带头人,先导物成药性研究全国重点实验室副主任,上海交通大学、复旦大学、中国药科大学、同济大学兼职博士生导师,《中国医药工业杂志》副总编辑,科技部国家科技专家库专家,上海市药学会药物化学专业委员会委员,上海市科技专家库专家。主要从事中枢神经系统、靶向肿瘤免疫及心脑血管原创性新药成药性优化及医药品种的绿色工艺产业化开发研究。主持国家“十三五”“重大新药创制”专项、国家自然科学基金、上海市青年科技英才扬帆计划(首届)、上海市青年科技启明星等各类项目20余项。主持发现10余个高效低毒、具有自主知识产权及综合竞争优势的候选新药,完成多个医药品种绿色工艺产业化开发,荣获2024年第35届上海市优秀发明选拔赛优秀发明铜奖、2024年度上海药学科技奖优秀成果奖。先后获上海市青年科技英才、上海市青年五四奖章(个人)、上海市青年科技启明星、中国医药工业研究总院科技创新先进个人(首届)、国务院国资委“中央企业优秀共产党员”、上海市东方英才计划拔尖项目等荣誉称号。以第一或通信作者在JMC、EJMC、CCL等SCI期刊发表研究论文70余篇;进行国内外学术报告40余次;合著英文专业书籍4本;申请国内外发明专利60余项,专利许可转让20余项。目前带教、指导博士及硕士研究生20余名,其指导的毕业生连续多年荣获“上海市优秀毕业生”称号。

, correspAuthorsNote=
张庆伟,研究员,博士生导师,从事原创性新药研究及医药品种产业化开发研究。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=57iGvt2opE+oLwbMigMdwA==, magXml=q3q9ChWXWQbwBZ0KALZnPA==, pdfUrl=null, pdf=tYzriOiJXt43le6uvW8xCA==, pdfFileSize=1727091, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=i1S2/MwIaKx4inX5CV125A==, mapNumber=null, fund=null)}, authors=[Author(id=1325193426630738342, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325193426785927593, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, authorId=1325193426630738342, language=EN, stringName=Jiahui WANG, firstName=Jiahui, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.China State Institute of Pharmaceutical Industry, Shanghai 201203
2.National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325193426928533930, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, authorId=1325193426630738342, language=CN, stringName=王佳辉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.中国医药工业研究总院,上海 201203
2.上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203, bio={"content":"

王佳辉,博士研究生,专业方向:药物化学。

"}, bioImg=null, bioContent=

王佳辉,博士研究生,专业方向:药物化学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325193426412634527, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, xref=1., ext=[AuthorCompanyExt(id=1325193426425217440, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, companyId=1325193426412634527, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1325193426433606049, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, companyId=1325193426412634527, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海 201203)]), AuthorCompany(id=1325193426521686434, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, xref=2., ext=[AuthorCompanyExt(id=1325193426530075043, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, companyId=1325193426521686434, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., Shanghai 201203), AuthorCompanyExt(id=1325193426542657956, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, companyId=1325193426521686434, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203)])]), Author(id=1325193427008225708, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325193427108889007, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, authorId=1325193427008225708, language=EN, stringName=Bo HAN, firstName=Bo, middleName=null, lastName=HAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.China State Institute of Pharmaceutical Industry, Shanghai 201203
2.National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325193427188580784, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, authorId=1325193427008225708, language=CN, stringName=韩博, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.中国医药工业研究总院,上海 201203
2.上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325193426412634527, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, xref=1., ext=[AuthorCompanyExt(id=1325193426425217440, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, companyId=1325193426412634527, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1325193426433606049, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, companyId=1325193426412634527, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海 201203)]), AuthorCompany(id=1325193426521686434, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, xref=2., ext=[AuthorCompanyExt(id=1325193426530075043, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, companyId=1325193426521686434, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., Shanghai 201203), AuthorCompanyExt(id=1325193426542657956, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, companyId=1325193426521686434, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203)])]), Author(id=1325193427268272562, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325193427389907381, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, authorId=1325193427268272562, language=EN, stringName=Zixue ZHANG, firstName=Zixue, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.China State Institute of Pharmaceutical Industry, Shanghai 201203
2.National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325193427486376374, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, authorId=1325193427268272562, language=CN, stringName=张子学, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.中国医药工业研究总院,上海 201203
2.上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325193426412634527, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, xref=1., ext=[AuthorCompanyExt(id=1325193426425217440, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, companyId=1325193426412634527, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1325193426433606049, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, companyId=1325193426412634527, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海 201203)]), AuthorCompany(id=1325193426521686434, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, xref=2., ext=[AuthorCompanyExt(id=1325193426530075043, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, companyId=1325193426521686434, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., Shanghai 201203), AuthorCompanyExt(id=1325193426542657956, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, companyId=1325193426521686434, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203)])]), Author(id=1325193427591233976, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1325193427683508667, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, authorId=1325193427591233976, language=EN, stringName=Qingwei ZHANG, firstName=Qingwei, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.China State Institute of Pharmaceutical Industry, Shanghai 201203
2.National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325193427771589052, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, authorId=1325193427591233976, language=CN, stringName=张庆伟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.中国医药工业研究总院,上海 201203
2.上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203, bio={"img":"UCz8yzg/JLxDFzqy2pUIHQ==","content":"

张庆伟,医学博士,中国医药工业研究总院研究员、博士生导师,院一级学科带头人,先导物成药性研究全国重点实验室副主任,上海交通大学、复旦大学、中国药科大学、同济大学兼职博士生导师,《中国医药工业杂志》副总编辑,科技部国家科技专家库专家,上海市药学会药物化学专业委员会委员,上海市科技专家库专家。主要从事中枢神经系统、靶向肿瘤免疫及心脑血管原创性新药成药性优化及医药品种的绿色工艺产业化开发研究。主持国家“十三五”“重大新药创制”专项、国家自然科学基金、上海市青年科技英才扬帆计划(首届)、上海市青年科技启明星等各类项目20余项。主持发现10余个高效低毒、具有自主知识产权及综合竞争优势的候选新药,完成多个医药品种绿色工艺产业化开发,荣获2024年第35届上海市优秀发明选拔赛优秀发明铜奖、2024年度上海药学科技奖优秀成果奖。先后获上海市青年科技英才、上海市青年五四奖章(个人)、上海市青年科技启明星、中国医药工业研究总院科技创新先进个人(首届)、国务院国资委“中央企业优秀共产党员”、上海市东方英才计划拔尖项目等荣誉称号。以第一或通信作者在JMC、EJMC、CCL等SCI期刊发表研究论文70余篇;进行国内外学术报告40余次;合著英文专业书籍4本;申请国内外发明专利60余项,专利许可转让20余项。目前带教、指导博士及硕士研究生20余名,其指导的毕业生连续多年荣获“上海市优秀毕业生”称号。

"}, bioImg=UCz8yzg/JLxDFzqy2pUIHQ==, bioContent=

张庆伟,医学博士,中国医药工业研究总院研究员、博士生导师,院一级学科带头人,先导物成药性研究全国重点实验室副主任,上海交通大学、复旦大学、中国药科大学、同济大学兼职博士生导师,《中国医药工业杂志》副总编辑,科技部国家科技专家库专家,上海市药学会药物化学专业委员会委员,上海市科技专家库专家。主要从事中枢神经系统、靶向肿瘤免疫及心脑血管原创性新药成药性优化及医药品种的绿色工艺产业化开发研究。主持国家“十三五”“重大新药创制”专项、国家自然科学基金、上海市青年科技英才扬帆计划(首届)、上海市青年科技启明星等各类项目20余项。主持发现10余个高效低毒、具有自主知识产权及综合竞争优势的候选新药,完成多个医药品种绿色工艺产业化开发,荣获2024年第35届上海市优秀发明选拔赛优秀发明铜奖、2024年度上海药学科技奖优秀成果奖。先后获上海市青年科技英才、上海市青年五四奖章(个人)、上海市青年科技启明星、中国医药工业研究总院科技创新先进个人(首届)、国务院国资委“中央企业优秀共产党员”、上海市东方英才计划拔尖项目等荣誉称号。以第一或通信作者在JMC、EJMC、CCL等SCI期刊发表研究论文70余篇;进行国内外学术报告40余次;合著英文专业书籍4本;申请国内外发明专利60余项,专利许可转让20余项。目前带教、指导博士及硕士研究生20余名,其指导的毕业生连续多年荣获“上海市优秀毕业生”称号。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325193426412634527, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, xref=1., ext=[AuthorCompanyExt(id=1325193426425217440, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, companyId=1325193426412634527, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1325193426433606049, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, companyId=1325193426412634527, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海 201203)]), AuthorCompany(id=1325193426521686434, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, xref=2., ext=[AuthorCompanyExt(id=1325193426530075043, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, companyId=1325193426521686434, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., Shanghai 201203), AuthorCompanyExt(id=1325193426542657956, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, companyId=1325193426521686434, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203)])])], keywords=[Keyword(id=1325193427880640957, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, language=EN, orderNo=1, keyword=FDA), Keyword(id=1325193427968721342, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, language=EN, orderNo=2, keyword=new drug approval), Keyword(id=1325193428044218815, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, language=EN, orderNo=3, keyword=indication), Keyword(id=1325193428115521984, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, language=EN, orderNo=4, keyword=mechanism of action), Keyword(id=1325193428191019457, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, language=EN, orderNo=5, keyword=synthetic route), Keyword(id=1325193428295877058, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, language=CN, orderNo=1, keyword=FDA), Keyword(id=1325193429973598659, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, language=CN, orderNo=2, keyword=新药上市), Keyword(id=1325193430078456260, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, language=CN, orderNo=3, keyword=适应证), Keyword(id=1325193430162342341, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, language=CN, orderNo=4, keyword=作用机制), Keyword(id=1325193430263005638, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, language=CN, orderNo=5, keyword=合成路线)], refs=[Reference(id=1325193430544024008, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=毕思举, 林快乐, 刘玲玲, 等.2022年美国FDA批准上市的新药简介[J].中国医药工业杂志, 2023, 54(1): 1-18., articleTitle=null, refAbstract=null), Reference(id=1325193430632104393, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=周 薇, 林快乐, 周伟澄.2023年美国FDA批准上市的新药简介[J].中国医药工业杂志, 2024, 55(1): 1-27., articleTitle=null, refAbstract=null), Reference(id=1325193430711796170, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=韩 博, 张庆伟.2024年美国FDA批准上市新药简介[J].中国医药工业杂志, 2025, 56(1): 1-27., articleTitle=null, refAbstract=null), Reference(id=1325193430787293643, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Novel drug approvals for 2025 [EB/OL].(2024-12-05)[2025-12-30].https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2025., articleTitle=null, refAbstract=null), Reference(id=1325193430900539852, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=KUMAR S A, SAURABH U, HEENA D, et al.A process for the preparation of treosulfan: WO, 2019043587A2 [P].2019-03-07., articleTitle=null, refAbstract=null), Reference(id=1325193431038951885, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=IRDAM E.Compositions of essentially pure form Ⅳ of N-[(R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereof: US,11066358B1 [P].2021-07-20., articleTitle=null, refAbstract=null), Reference(id=1325193431156392398, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=KAUFMAN M D, FLYNN D, AHN Y, et al.2-Aminopyrimidin-6-ones and analogs exhibit anti-cancer and anti-proliferative activities: US, 20140275085A1 [P].2014-09-18., articleTitle=null, refAbstract=null), Reference(id=1325193431374496207, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=IIKURA H, HYOUDOH I, AOKI T, et al.Coumarin derivative having antitumor activity: US, 7897792B2 [P].2011-03-01., articleTitle=null, refAbstract=null), Reference(id=1325193431483548112, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=F R E E M A N-C O O K K D, H AY WA R D M M,BHATTACHARYA S K, et al.Sulfonyl amide derivatives for the treatment of abnormal cell growth: WO, 2008129380A1[P].2008-10-30., articleTitle=null, refAbstract=null), Reference(id=1325193431785538001, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=TAKEDA Y, YOSHIKAWA K, KAGOSHIMA Y, et al.Imidazo[1,2-b]pyridazine derivatives as kinase inhibitors: US,20150051190A1 [P].2015-02-19., articleTitle=null, refAbstract=null), Reference(id=1325193431919755730, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=CHEN X, ZHANG X, ZHU W, et al.ERBB/BTK inhibitors:WO, 2019149164A1 [P].2019-08-08., articleTitle=null, refAbstract=null), Reference(id=1325193431999447507, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=JANDA K D, LOCKNER J W, JACOB N T.Pharmacophore for trail induction: WO, 2015153468A1 [P].2015-10-08., articleTitle=null, refAbstract=null), Reference(id=1325193432217551316, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=KLEIN C, ETTMAYER P, MANTOULIDIS A, et al.Pyrido-[5,4-d] pyrimidines as cell proliferation inhibitors: WO,2010026262A1 [P].2010-03-11., articleTitle=null, refAbstract=null), Reference(id=1325193432355963349, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=ARGUELLES D A J, CZESKIS B A, HAWK M K N, et al.Processes for the preparation of selective estrogen receptor degraders: WO, 2023150056A1 [P].2023-08-10., articleTitle=null, refAbstract=null), Reference(id=1325193432448238038, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=FRANCIS B.Treatment of hematological malignancies with inhibitors of menin: WO, 2020069027A1 [P].2020-04-02., articleTitle=null, refAbstract=null), Reference(id=1325193432553095639, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=GRAHAM K, BERGER M, SIEGEL S, et al.4H-Pyrrolo[3,2-c]pyridin-4-one compounds: WO,2020216781A1 [P].2020-10-29., articleTitle=null, refAbstract=null), Reference(id=1325193432641176024, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=HEEREN M G, MITCHELL A D, JILL M S, et al.N-substituted C6 cyclyl carboxamide compounds and uses thereof: WO, 2024220876A1 [P].2024-10-24., articleTitle=null, refAbstract=null), Reference(id=1325193432725062105, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=CONNOLLY S, AURELL C, SWALLOW S, et al.(2S)-N-[(1S)-1-Cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidaseⅠinhibitors: WO,2015110826A1 [P].2015-07-30., articleTitle=null, refAbstract=null), Reference(id=1325193432817336794, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=KIM S, WERTHMANN U, YANG B, et al.Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma: WO, 2013026797A1 [P].2013-02-28., articleTitle=null, refAbstract=null), Reference(id=1325193434574750171, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=INOUE M, YAMANAKA H, SHIOZAKI M, et al.Nitrogen-containing spiro-ring compound and medicinal use of same:WO, 2011013785A1 [P].2011-02-03., articleTitle=null, refAbstract=null), Reference(id=1325193434851574236, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=ANGST D, VULPETTI A, GESSIER F, et al.Novel amino pyrimidine derivatives: WO, 2015079417A1 [P].2015-06-04., articleTitle=null, refAbstract=null), Reference(id=1325193435182924253, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=HODGSON S T, EVANS D M, DAVIE R L, et al.N-[(HET)-arylmethyl]-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors: WO, 2016083820A1 [P].2016-06-02., articleTitle=null, refAbstract=null), Reference(id=1325193435707212254, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=REDDY J P, MAHMOUD M, KOTA M, et al.Process of making somatostatin modulators: US, 20190218202A1 [P].2019-07-18., articleTitle=null, refAbstract=null), Reference(id=1325193436021785055, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=YOSHINO H, KURODA Y, SHIRO Y, et al.Method for producing sepiapterin and tetrahydrolactoylpterin: WO,2013168693A1 [P].2013-11-14., articleTitle=null, refAbstract=null), Reference(id=1325193436130836960, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=DURRANT S.Polysubstituted pyrrolidine derivative,preparation method therefor and use thereof: WO,2021113627A1 [P].2021-06-10., articleTitle=null, refAbstract=null), Reference(id=1325193436512518625, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=DAVIES D T, PEARSON N D, DAVIES D E, et al.Tricyclic nitrogen containing compounds as antibacterial agents: WO,2008128942A1 [P].2008-04-16., articleTitle=null, refAbstract=null), Reference(id=1325193436860645858, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=WINN MARTIN, BOYD S A, STEVEN A B, et al.Endothelin antagonists: WO, 1996006095A1 [P].1995-08-04., articleTitle=null, refAbstract=null), Reference(id=1325193436973892067, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=VERNER E, OWENS T.Pyrazolopyrimidine compounds as kinase inhibitors: WO, 2014039899A1 [P].2014-03-13., articleTitle=null, refAbstract=null), Reference(id=1325193437326213604, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=OUDENES J, ANDERSEN M W, DUNCAN S M, et al.N-Carboxyanhydride-based-scale synthesis of elamipretide:WO, 2018034901A1 [P].2018-02-22., articleTitle=null, refAbstract=null), Reference(id=1325193439037489637, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=DI F R, FALCHI A, FALCHI A, et al.Pyridine derivatives and their use in the treatment of psychotic disorders: WO,2007028654A1 [P].2007-03-15., articleTitle=null, refAbstract=null), Reference(id=1325193439356256742, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHOU F, BASARAB G S, GOWRAVARAM M R, et al.Compounds and methods for treating bacterial infections: WO,2014114929A1 [P].2014-07-31., articleTitle=null, refAbstract=null), Reference(id=1325193439507251687, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=RIOUX E, MAGUIRE M P, LEIGHTON H J.Short acting phenylalkylamine calcium channel blockers and uses thereof:WO, 2008156820A1 [P].2008-12-24., articleTitle=null, refAbstract=null), Reference(id=1325193439809241576, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=MORGAN B P, ASHCRAFT L W, WANG W, et al.Dihydrobenzofuran and inden analogs as cardiac sarcomere inhibitors: WO, 2019144041A1 [P].2019-07-25., articleTitle=null, refAbstract=null), Reference(id=1325193439901516265, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=WILSON T M, KOBIERSKI M E, KOPACH M E.Process development of a pyridine-containing NK-1 receptor antagonist: WO, 2017031215A1 [P].2017-02-23., articleTitle=null, refAbstract=null)], funds=[Fund(id=1325193430414000583, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, awardId=NKLYT2023007, language=CN, fundingSource=先导物成药性研究全国重点实验室自主研究课题(NKLYT2023007), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1325193426412634527, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, xref=1., ext=[AuthorCompanyExt(id=1325193426425217440, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, companyId=1325193426412634527, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1325193426433606049, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, companyId=1325193426412634527, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海 201203)]), AuthorCompany(id=1325193426521686434, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, xref=2., ext=[AuthorCompanyExt(id=1325193426530075043, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, companyId=1325193426521686434, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., Shanghai 201203), AuthorCompanyExt(id=1325193426542657956, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, companyId=1325193426521686434, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2026.01.001, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2026.01.001, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2026.01.001, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2026.01.001, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1767974400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
2025年美国FDA批准上市新药简介
王佳辉 1, 2 , 韩博 1, 2 , 张子学 1, 2 , 张庆伟 1, 2, *
中国医药工业杂志 | 专论与综述 2026,57(1): 1-28
收起
收藏切换
中国医药工业杂志 |专论与综述 2026 , 57 (1) : 1 -28
2025年美国FDA批准上市新药简介
全屏
[Author(id=1325193426630738342, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325193426785927593, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, authorId=1325193426630738342, language=EN, stringName=Jiahui WANG, firstName=Jiahui, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.China State Institute of Pharmaceutical Industry, Shanghai 201203
2.National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325193426928533930, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, authorId=1325193426630738342, language=CN, stringName=王佳辉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.中国医药工业研究总院,上海 201203
2.上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203, bio={"content":"

王佳辉,博士研究生,专业方向:药物化学。

"}, bioImg=null, bioContent=

王佳辉,博士研究生,专业方向:药物化学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325193426412634527, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, xref=1., ext=[AuthorCompanyExt(id=1325193426425217440, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, companyId=1325193426412634527, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1325193426433606049, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, companyId=1325193426412634527, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海 201203)]), AuthorCompany(id=1325193426521686434, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, xref=2., ext=[AuthorCompanyExt(id=1325193426530075043, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, companyId=1325193426521686434, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., Shanghai 201203), AuthorCompanyExt(id=1325193426542657956, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, companyId=1325193426521686434, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203)])]), Author(id=1325193427008225708, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325193427108889007, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, authorId=1325193427008225708, language=EN, stringName=Bo HAN, firstName=Bo, middleName=null, lastName=HAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.China State Institute of Pharmaceutical Industry, Shanghai 201203
2.National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325193427188580784, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, authorId=1325193427008225708, language=CN, stringName=韩博, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.中国医药工业研究总院,上海 201203
2.上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325193426412634527, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, xref=1., ext=[AuthorCompanyExt(id=1325193426425217440, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, companyId=1325193426412634527, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1325193426433606049, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, companyId=1325193426412634527, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海 201203)]), AuthorCompany(id=1325193426521686434, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, xref=2., ext=[AuthorCompanyExt(id=1325193426530075043, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, companyId=1325193426521686434, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., Shanghai 201203), AuthorCompanyExt(id=1325193426542657956, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, companyId=1325193426521686434, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203)])]), Author(id=1325193427268272562, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325193427389907381, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, authorId=1325193427268272562, language=EN, stringName=Zixue ZHANG, firstName=Zixue, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.China State Institute of Pharmaceutical Industry, Shanghai 201203
2.National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325193427486376374, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, authorId=1325193427268272562, language=CN, stringName=张子学, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.中国医药工业研究总院,上海 201203
2.上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325193426412634527, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, xref=1., ext=[AuthorCompanyExt(id=1325193426425217440, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, companyId=1325193426412634527, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1325193426433606049, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, companyId=1325193426412634527, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海 201203)]), AuthorCompany(id=1325193426521686434, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, xref=2., ext=[AuthorCompanyExt(id=1325193426530075043, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, companyId=1325193426521686434, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., Shanghai 201203), AuthorCompanyExt(id=1325193426542657956, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, companyId=1325193426521686434, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203)])]), Author(id=1325193427591233976, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1325193427683508667, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, authorId=1325193427591233976, language=EN, stringName=Qingwei ZHANG, firstName=Qingwei, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.China State Institute of Pharmaceutical Industry, Shanghai 201203
2.National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325193427771589052, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, authorId=1325193427591233976, language=CN, stringName=张庆伟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.中国医药工业研究总院,上海 201203
2.上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203, bio={"img":"UCz8yzg/JLxDFzqy2pUIHQ==","content":"

张庆伟,医学博士,中国医药工业研究总院研究员、博士生导师,院一级学科带头人,先导物成药性研究全国重点实验室副主任,上海交通大学、复旦大学、中国药科大学、同济大学兼职博士生导师,《中国医药工业杂志》副总编辑,科技部国家科技专家库专家,上海市药学会药物化学专业委员会委员,上海市科技专家库专家。主要从事中枢神经系统、靶向肿瘤免疫及心脑血管原创性新药成药性优化及医药品种的绿色工艺产业化开发研究。主持国家“十三五”“重大新药创制”专项、国家自然科学基金、上海市青年科技英才扬帆计划(首届)、上海市青年科技启明星等各类项目20余项。主持发现10余个高效低毒、具有自主知识产权及综合竞争优势的候选新药,完成多个医药品种绿色工艺产业化开发,荣获2024年第35届上海市优秀发明选拔赛优秀发明铜奖、2024年度上海药学科技奖优秀成果奖。先后获上海市青年科技英才、上海市青年五四奖章(个人)、上海市青年科技启明星、中国医药工业研究总院科技创新先进个人(首届)、国务院国资委“中央企业优秀共产党员”、上海市东方英才计划拔尖项目等荣誉称号。以第一或通信作者在JMC、EJMC、CCL等SCI期刊发表研究论文70余篇;进行国内外学术报告40余次;合著英文专业书籍4本;申请国内外发明专利60余项,专利许可转让20余项。目前带教、指导博士及硕士研究生20余名,其指导的毕业生连续多年荣获“上海市优秀毕业生”称号。

"}, bioImg=UCz8yzg/JLxDFzqy2pUIHQ==, bioContent=

张庆伟,医学博士,中国医药工业研究总院研究员、博士生导师,院一级学科带头人,先导物成药性研究全国重点实验室副主任,上海交通大学、复旦大学、中国药科大学、同济大学兼职博士生导师,《中国医药工业杂志》副总编辑,科技部国家科技专家库专家,上海市药学会药物化学专业委员会委员,上海市科技专家库专家。主要从事中枢神经系统、靶向肿瘤免疫及心脑血管原创性新药成药性优化及医药品种的绿色工艺产业化开发研究。主持国家“十三五”“重大新药创制”专项、国家自然科学基金、上海市青年科技英才扬帆计划(首届)、上海市青年科技启明星等各类项目20余项。主持发现10余个高效低毒、具有自主知识产权及综合竞争优势的候选新药,完成多个医药品种绿色工艺产业化开发,荣获2024年第35届上海市优秀发明选拔赛优秀发明铜奖、2024年度上海药学科技奖优秀成果奖。先后获上海市青年科技英才、上海市青年五四奖章(个人)、上海市青年科技启明星、中国医药工业研究总院科技创新先进个人(首届)、国务院国资委“中央企业优秀共产党员”、上海市东方英才计划拔尖项目等荣誉称号。以第一或通信作者在JMC、EJMC、CCL等SCI期刊发表研究论文70余篇;进行国内外学术报告40余次;合著英文专业书籍4本;申请国内外发明专利60余项,专利许可转让20余项。目前带教、指导博士及硕士研究生20余名,其指导的毕业生连续多年荣获“上海市优秀毕业生”称号。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325193426412634527, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, xref=1., ext=[AuthorCompanyExt(id=1325193426425217440, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, companyId=1325193426412634527, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1325193426433606049, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, companyId=1325193426412634527, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海 201203)]), AuthorCompany(id=1325193426521686434, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, xref=2., ext=[AuthorCompanyExt(id=1325193426530075043, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, companyId=1325193426521686434, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., Shanghai 201203), AuthorCompanyExt(id=1325193426542657956, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325193423690531226, companyId=1325193426521686434, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203)])])]
王佳辉1, 2, 韩博1, 2, 张子学1, 2, 张庆伟1, 2, *
作者信息
  • 1.中国医药工业研究总院,上海 201203
  • 2.上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203
通讯作者:
张庆伟,研究员,博士生导师,从事原创性新药研究及医药品种产业化开发研究。
作者简介:

王佳辉,博士研究生,专业方向:药物化学。

张庆伟,医学博士,中国医药工业研究总院研究员、博士生导师,院一级学科带头人,先导物成药性研究全国重点实验室副主任,上海交通大学、复旦大学、中国药科大学、同济大学兼职博士生导师,《中国医药工业杂志》副总编辑,科技部国家科技专家库专家,上海市药学会药物化学专业委员会委员,上海市科技专家库专家。主要从事中枢神经系统、靶向肿瘤免疫及心脑血管原创性新药成药性优化及医药品种的绿色工艺产业化开发研究。主持国家“十三五”“重大新药创制”专项、国家自然科学基金、上海市青年科技英才扬帆计划(首届)、上海市青年科技启明星等各类项目20余项。主持发现10余个高效低毒、具有自主知识产权及综合竞争优势的候选新药,完成多个医药品种绿色工艺产业化开发,荣获2024年第35届上海市优秀发明选拔赛优秀发明铜奖、2024年度上海药学科技奖优秀成果奖。先后获上海市青年科技英才、上海市青年五四奖章(个人)、上海市青年科技启明星、中国医药工业研究总院科技创新先进个人(首届)、国务院国资委“中央企业优秀共产党员”、上海市东方英才计划拔尖项目等荣誉称号。以第一或通信作者在JMC、EJMC、CCL等SCI期刊发表研究论文70余篇;进行国内外学术报告40余次;合著英文专业书籍4本;申请国内外发明专利60余项,专利许可转让20余项。目前带教、指导博士及硕士研究生20余名,其指导的毕业生连续多年荣获“上海市优秀毕业生”称号。

Overviews of the New Drugs in 2025 Approved by U.S. FDA
Jiahui WANG1, 2, Bo HAN1, 2, Zixue ZHANG1, 2, Qingwei ZHANG1, 2, *
Affiliations
  • 1.China State Institute of Pharmaceutical Industry, Shanghai 201203
  • 2.National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., Shanghai 201203
出版时间: 2026-01-10 doi: 10.16522/j.cnki.cjph.2026.01.001
文章导航
收藏切换

2025年美国FDA批准上市新药46个,其中小分子药物31个,生物制品15个。根据FDA批准的新药说明书以及相关数据库、专利、文献报道,文章简要介绍了2025年FDA批准上市的小分子药物的化学名、原研公司、化合物专刊、上市时间、适应证、作用机制、剂型和规格、不良反应及合成路线等,以及生物制品的基本情况。

FDA  /  新药上市  /  适应证  /  作用机制  /  合成路线

In 2025, FDA approved 46 new drugs for marketing, including 31 small molecule drugs and 15 biological products. Based on FDA-approved drug labeling, related databases, patents, and published literature, this review describes the chemical name, original research company, compound patent, time to market, indications, mechanism of action, dosage form and strengths, adverse effects and synthesis routes of those small molecule drugs, and the basic information about biological products.

FDA  /  new drug approval  /  indication  /  mechanism of action  /  synthetic route
王佳辉, 韩博, 张子学, 张庆伟. 2025年美国FDA批准上市新药简介. 中国医药工业杂志, 2026 , 57 (1) : 1 -28 . DOI: 10.16522/j.cnki.cjph.2026.01.001
Jiahui WANG, Bo HAN, Zixue ZHANG, Qingwei ZHANG. Overviews of the New Drugs in 2025 Approved by U.S. FDA[J]. Chinese Journal of Pharmaceuticals, 2026 , 57 (1) : 1 -28 . DOI: 10.16522/j.cnki.cjph.2026.01.001
  • 先导物成药性研究全国重点实验室自主研究课题(NKLYT2023007)
参考文献 引证文献
排序方式:
[1]
毕思举, 林快乐, 刘玲玲, 等.2022年美国FDA批准上市的新药简介[J].中国医药工业杂志, 2023, 54(1): 1-18.
[2]
周 薇, 林快乐, 周伟澄.2023年美国FDA批准上市的新药简介[J].中国医药工业杂志, 2024, 55(1): 1-27.
[3]
韩 博, 张庆伟.2024年美国FDA批准上市新药简介[J].中国医药工业杂志, 2025, 56(1): 1-27.
[4]
FDA.Novel drug approvals for 2025 [EB/OL].(2024-12-05)[2025-12-30].https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2025.
[5]
KUMAR S A, SAURABH U, HEENA D, et al.A process for the preparation of treosulfan: WO, 2019043587A2 [P].2019-03-07.
[6]
IRDAM E.Compositions of essentially pure form Ⅳ of N-[(R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereof: US,11066358B1 [P].2021-07-20.
[7]
KAUFMAN M D, FLYNN D, AHN Y, et al.2-Aminopyrimidin-6-ones and analogs exhibit anti-cancer and anti-proliferative activities: US, 20140275085A1 [P].2014-09-18.
[8]
IIKURA H, HYOUDOH I, AOKI T, et al.Coumarin derivative having antitumor activity: US, 7897792B2 [P].2011-03-01.
[9]
F R E E M A N-C O O K K D, H AY WA R D M M,BHATTACHARYA S K, et al.Sulfonyl amide derivatives for the treatment of abnormal cell growth: WO, 2008129380A1[P].2008-10-30.
[10]
TAKEDA Y, YOSHIKAWA K, KAGOSHIMA Y, et al.Imidazo[1,2-b]pyridazine derivatives as kinase inhibitors: US,20150051190A1 [P].2015-02-19.
[11]
CHEN X, ZHANG X, ZHU W, et al.ERBB/BTK inhibitors:WO, 2019149164A1 [P].2019-08-08.
[12]
JANDA K D, LOCKNER J W, JACOB N T.Pharmacophore for trail induction: WO, 2015153468A1 [P].2015-10-08.
[13]
KLEIN C, ETTMAYER P, MANTOULIDIS A, et al.Pyrido-[5,4-d] pyrimidines as cell proliferation inhibitors: WO,2010026262A1 [P].2010-03-11.
[14]
ARGUELLES D A J, CZESKIS B A, HAWK M K N, et al.Processes for the preparation of selective estrogen receptor degraders: WO, 2023150056A1 [P].2023-08-10.
[15]
FRANCIS B.Treatment of hematological malignancies with inhibitors of menin: WO, 2020069027A1 [P].2020-04-02.
[16]
GRAHAM K, BERGER M, SIEGEL S, et al.4H-Pyrrolo[3,2-c]pyridin-4-one compounds: WO,2020216781A1 [P].2020-10-29.
[17]
HEEREN M G, MITCHELL A D, JILL M S, et al.N-substituted C6 cyclyl carboxamide compounds and uses thereof: WO, 2024220876A1 [P].2024-10-24.
[18]
CONNOLLY S, AURELL C, SWALLOW S, et al.(2S)-N-[(1S)-1-Cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidaseⅠinhibitors: WO,2015110826A1 [P].2015-07-30.
[19]
KIM S, WERTHMANN U, YANG B, et al.Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma: WO, 2013026797A1 [P].2013-02-28.
[20]
INOUE M, YAMANAKA H, SHIOZAKI M, et al.Nitrogen-containing spiro-ring compound and medicinal use of same:WO, 2011013785A1 [P].2011-02-03.
[21]
ANGST D, VULPETTI A, GESSIER F, et al.Novel amino pyrimidine derivatives: WO, 2015079417A1 [P].2015-06-04.
[22]
HODGSON S T, EVANS D M, DAVIE R L, et al.N-[(HET)-arylmethyl]-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors: WO, 2016083820A1 [P].2016-06-02.
[23]
REDDY J P, MAHMOUD M, KOTA M, et al.Process of making somatostatin modulators: US, 20190218202A1 [P].2019-07-18.
[24]
YOSHINO H, KURODA Y, SHIRO Y, et al.Method for producing sepiapterin and tetrahydrolactoylpterin: WO,2013168693A1 [P].2013-11-14.
[25]
DURRANT S.Polysubstituted pyrrolidine derivative,preparation method therefor and use thereof: WO,2021113627A1 [P].2021-06-10.
[26]
DAVIES D T, PEARSON N D, DAVIES D E, et al.Tricyclic nitrogen containing compounds as antibacterial agents: WO,2008128942A1 [P].2008-04-16.
[27]
WINN MARTIN, BOYD S A, STEVEN A B, et al.Endothelin antagonists: WO, 1996006095A1 [P].1995-08-04.
[28]
VERNER E, OWENS T.Pyrazolopyrimidine compounds as kinase inhibitors: WO, 2014039899A1 [P].2014-03-13.
[29]
OUDENES J, ANDERSEN M W, DUNCAN S M, et al.N-Carboxyanhydride-based-scale synthesis of elamipretide:WO, 2018034901A1 [P].2018-02-22.
[30]
DI F R, FALCHI A, FALCHI A, et al.Pyridine derivatives and their use in the treatment of psychotic disorders: WO,2007028654A1 [P].2007-03-15.
[31]
ZHOU F, BASARAB G S, GOWRAVARAM M R, et al.Compounds and methods for treating bacterial infections: WO,2014114929A1 [P].2014-07-31.
[32]
RIOUX E, MAGUIRE M P, LEIGHTON H J.Short acting phenylalkylamine calcium channel blockers and uses thereof:WO, 2008156820A1 [P].2008-12-24.
[33]
MORGAN B P, ASHCRAFT L W, WANG W, et al.Dihydrobenzofuran and inden analogs as cardiac sarcomere inhibitors: WO, 2019144041A1 [P].2019-07-25.
[34]
WILSON T M, KOBIERSKI M E, KOPACH M E.Process development of a pyridine-containing NK-1 receptor antagonist: WO, 2017031215A1 [P].2017-02-23.
2026年第57卷第1期
155
45
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2026.01.001
  • 接收时间:2025-12-15
  • 首发时间:2026-11-05
  • 出版时间:2026-01-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2025-12-15
基金
先导物成药性研究全国重点实验室自主研究课题(NKLYT2023007)
作者信息
    1.中国医药工业研究总院,上海 201203
    2.上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203

通讯作者:

张庆伟,研究员,博士生导师,从事原创性新药研究及医药品种产业化开发研究。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2026.01.001
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏